Pancreatic Clamp in NAFLD
Conditions: Insulin Resistance; Prediabetic State; Hyperinsulinemia; Non-Alcoholic Fatty Liver Disease; Obesity Interventions: Drug: Insulin human; Drug: Octreotide Acetate; Drug: Glucagon; Drug: Growth Hormone, Human; Other: [6,6-2H2] D-glucose; Drug: 20% D-glucose (aq); Dietary Supplement: BOOST Plus; Device: Harvard Apparatus PHD ULTRA CP syringe pump; Device: Yellow Springs In struments (YSI) 2500 Biochemistry Glucose/Lactate Analyzer Sponsors: Columbia University; Albert Einstein College of Medicine Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Biochemistry | Eating Disorders & Weight Management | Harvard | Hormones | Non-alcoholic Fatty Liver Diseases (NAFLD) | Nutrition | Obesity | Pancreas | Research